BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16916050)

  • 1. Maternal serum alpha fetoprotein among pregnant females in Alexandria.
    Baghagho EE; Kharboush IF; El-Kaffash DM; KarKour TA; Ismail SR; Mortada MM
    J Egypt Public Health Assoc; 2004; 79(1-2):59-81. PubMed ID: 16916050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twin pregnancies in the second trimester in women in an alpha-fetoprotein screening program: sonographic evaluation and outcome.
    Pretorius DH; Budorick NE; Scioscia AL; Krabbe JK; Ko S; Myhre CM
    AJR Am J Roentgenol; 1993 Nov; 161(5):1007-13. PubMed ID: 7506005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early pregnancy screening for neural tube defects in Israel.
    Legum C; Shomrat R; Yedwab G; Jaffa AJ; Rudick A
    Isr J Med Sci; 1986; 22(3-4):210-4. PubMed ID: 2427475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results and benefits of a maternal serum alpha-fetoprotein screening program.
    Milunsky A; Alpert E
    JAMA; 1984 Sep; 252(11):1438-42. PubMed ID: 6206249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of abnormally high and low maternal serum alpha-fetoprotein levels between 14 and 25 weeks of gestation.
    Ko TM; Hsieh FJ; Wu CC; Chang CH; Hsieh RF; Liu IJ; Hsieh CY; Lee TY
    J Formos Med Assoc; 1990 Jun; 89(6):456-60. PubMed ID: 1700059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
    Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
    J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcome(1).
    Krause TG; Christens P; Wohlfahrt J; Lei U; Westergaard T; Nørgaard-Pedersen B; Melbye M
    Obstet Gynecol; 2001 Feb; 97(2):277-82. PubMed ID: 11165595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: relation to fetal weight and preterm delivery.
    Morssink LP; Kornman LH; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1995 Nov; 15(11):1041-6. PubMed ID: 8606883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated maternal serum alpha-fetoprotein values. How low is high?
    Lenke RR; Guerrieri J; Nemes JM; Kurczynski TW; French B; Gray M; Schut H; Ashwood ER
    J Reprod Med; 1989 Aug; 34(8):511-6. PubMed ID: 2478705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
    Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
    J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss.
    Maher JE; Davis RO; Goldenberg RL; Boots LR; DuBard MB
    Obstet Gynecol; 1994 Jan; 83(1):138-41. PubMed ID: 7505911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies on maternal serum alpha-fetoprotein (MSAFP) of 532 cases--the median value, pregnancy outcomes and clinical evaluation].
    Hayashi M; Kohzu H
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1211-8. PubMed ID: 1385554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation between serum markers in the second trimester and placental pathology. A study on extremely small for gestational age fetuses.
    Morssink LP; de Wolf BT; Kornman LH; Beekhuis JR; van der Hall TP; Mantingh A
    Br J Obstet Gynaecol; 1996 Aug; 103(8):779-83. PubMed ID: 8760707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between maternal serum alpha-fetoprotein and adverse outcomes in pregnancies with placenta previa.
    Butler EL; Dashe JS; Ramus RM
    Obstet Gynecol; 2001 Jan; 97(1):35-8. PubMed ID: 11152903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of early third-trimester maternal serum alpha-fetoprotein determination.
    O'Brien WF; Sternlight D; Torres C; Knuppel RA; Montenegro R
    Prenat Diagn; 1990 Mar; 10(3):183-8. PubMed ID: 1692998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal serum alpha-fetoprotein levels in low birth weight singleton pregnancies.
    Buckland CM; Thom H; Campbell AG
    J Perinat Med; 1984; 12(3):127-32. PubMed ID: 6209381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
    Silver RM; Draper ML; Byrne JL; Ashwood EA; Lyon JL; Branch DW
    Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
    Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR
    Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low birth weight and preterm delivery in relation to early-gestation vaginal bleeding and elevated maternal serum alpha-fetoprotein.
    Williams MA; Hickok DE; Zingheim RW; Mittendorf R; Kimelman J; Mahony BS
    Obstet Gynecol; 1992 Nov; 80(5):745-9. PubMed ID: 1383900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.